X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with TTK HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE TTK HEALTHCARE SUVEN LIFE/
TTK HEALTHCARE
 
P/E (TTM) x 19.8 51.5 38.4% View Chart
P/BV x 3.7 9.5 38.7% View Chart
Dividend Yield % 1.0 0.3 332.9%  

Financials

 SUVEN LIFE   TTK HEALTHCARE
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
TTK HEALTHCARE
Mar-14
SUVEN LIFE/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs339663 51.0%   
Low Rs144399 36.2%   
Sales per share (Unadj.) Rs39.2535.6 7.3%  
Earnings per share (Unadj.) Rs7.515.9 46.8%  
Cash flow per share (Unadj.) Rs8.820.0 43.8%  
Dividends per share (Unadj.) Rs2.004.00 50.0%  
Dividend yield (eoy) %0.80.8 110.0%  
Book value per share (Unadj.) Rs49.0137.6 35.6%  
Shares outstanding (eoy) m127.287.77 1,638.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.21.0 620.3%   
Avg P/E ratio x32.433.3 97.1%  
P/CF ratio (eoy) x27.526.5 103.7%  
Price / Book Value ratio x4.93.9 127.7%  
Dividend payout %26.825.1 106.9%   
Avg Mkt Cap Rs m30,7324,127 744.6%   
No. of employees `0001.01.7 55.9%   
Total wages/salary Rs m416607 68.6%   
Avg. sales/employee Rs Th5,236.12,436.7 214.9%   
Avg. wages/employee Rs Th436.5355.2 122.9%   
Avg. net profit/employee Rs Th995.572.5 1,372.3%   
INCOME DATA
Net Sales Rs m4,9954,162 120.0%  
Other income Rs m19461 316.2%   
Total revenues Rs m5,1894,223 122.9%   
Gross profit Rs m1,233197 625.4%  
Depreciation Rs m16732 527.4%   
Interest Rs m5430 181.3%   
Profit before tax Rs m1,205197 612.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m25573 350.3%   
Profit after tax Rs m950124 766.5%  
Gross profit margin %24.74.7 521.0%  
Effective tax rate %21.237.0 57.2%   
Net profit margin %19.03.0 638.6%  
BALANCE SHEET DATA
Current assets Rs m4,9861,629 306.1%   
Current liabilities Rs m1,0421,058 98.5%   
Net working cap to sales %79.013.7 575.6%  
Current ratio x4.81.5 310.7%  
Inventory Days Days6130 204.8%  
Debtors Days Days3934 116.5%  
Net fixed assets Rs m3,126556 561.8%   
Share capital Rs m12778 163.8%   
"Free" reserves Rs m3,717878 423.2%   
Net worth Rs m6,2361,069 583.2%   
Long term debt Rs m432159 272.4%   
Total assets Rs m8,0792,399 336.7%  
Interest coverage x23.27.6 306.5%   
Debt to equity ratio x0.10.1 46.7%  
Sales to assets ratio x0.61.7 35.6%   
Return on assets %12.46.4 193.9%  
Return on equity %15.211.6 131.4%  
Return on capital %18.918.5 102.3%  
Exports to sales %87.50.8 11,067.9%   
Imports to sales %12.21.4 872.9%   
Exports (fob) Rs m4,37133 13,284.2%   
Imports (cif) Rs m61158 1,047.7%   
Fx inflow Rs m4,66633 14,183.8%   
Fx outflow Rs m94263 1,490.9%   
Net fx Rs m3,724-30 -12,295.6%   
CASH FLOW
From Operations Rs m922127 728.3%  
From Investments Rs m-619-146 424.2%  
From Financial Activity Rs m-69822 -3,189.0%  
Net Cashflow Rs m-3963 -15,828.0%  

Share Holding

Indian Promoters % 63.4 65.4 96.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 0.0 5.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 25.8 141.5%  
Shareholders   37,287 12,723 293.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   VENUS REMEDIES  SHASUN PHARMA  PFIZER  GLENMARK PHARMA  ORCHID PHARMA LTD  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Feb 16, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - TTK HEALTHCARE COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS